Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Preferred Stock Liabilities (2018 - 2019)

Historic Preferred Stock Liabilities for Bio (TELA) over the last 2 years, with Q3 2019 value amounting to $145.4 million.

  • Bio's Preferred Stock Liabilities changed N/A to $145.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was $145.4 million, marking a year-over-year change of. This contributed to the annual value of $124.2 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q3 2019, Bio's Preferred Stock Liabilities is $145.4 million.
  • Bio's 5-year Preferred Stock Liabilities high stood at $145.4 million for Q3 2019, and its period low was $124.2 million during Q4 2018.